lncARSR may serve as an effective molecular marker and intervention target to improve the therapeutic efficacy of sunitinib in renal cell carcinoma and provide a new approach and perspective for the individualized target therapy of renal cell carcinoma. This evidence concerns the gene LNCARSR and renal cell carcinoma.